10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001104659-16-137913`
Period End Date	20160630
Filing Date	20160808
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	cldx-20160630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 61 Cash Flow Statement 56

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$81.58M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$32.48M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.02M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$72.11M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$217.78M	USD	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$187.65M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$970.00K	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.12M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$7.54M	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.08M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$228.78M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	99.39M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	98.69M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$294.94M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$11.29M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	99.39M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$11.46M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	98.69M	shares	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$20.79M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$20.29M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$1.43M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$1.88M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Total Assets	`Assets`	$337.58M	USD	Point-in-time
Total Assets	`Assets`	$271.21M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.51M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$706.00K	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$24.32M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$14.94M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$4.36M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$4.42M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$20.00M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$30.24M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$16.49M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$17.24M	USD	Point-in-time
Total Liabilities	`Liabilities`	$47.48M	USD	Point-in-time
Total Liabilities	`Liabilities`	$36.50M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2016 and December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2016 and December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 99,394,537 and 98,685,595 Shares Issued and Outstanding at June 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$99.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 99,394,537 and 98,685,595 Shares Issued and Outstanding at June 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$99.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$878.65M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$889.47M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.72M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.31M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-590.96M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-657.58M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$290.11M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$234.71M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$337.58M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$271.21M	USD	Point-in-time

Income Statement 61 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$334.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$676.00K	USD	2 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$1.06M	USD	2 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$604.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$1.99M	USD	2 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$1.84M	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$1.64M	USD	2 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$785.00K	USD	1 Quarter
Total Revenue	`Revenues`	$2.18M	USD	1 Quarter
Total Revenue	`Revenues`	$1.39M	USD	1 Quarter
Total Revenue	`Revenues`	$2.69M	USD	2 Qtrs
Total Revenue	`Revenues`	$2.66M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$25.71M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$53.16M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$51.62M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$26.49M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$17.10M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$14.27M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$7.79M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$8.18M	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$34.93M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$33.76M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$70.76M	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$66.39M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-32.75M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-68.07M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-32.37M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-63.73M	USD	2 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$391.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$414.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.45M	USD	2 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.20M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-31.95M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-62.53M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-32.36M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-66.62M	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.67	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.32	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.65	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.33	USD	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	98.48M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	95.48M	shares	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	98.75M	shares	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	98.82M	shares	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-31.95M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-62.53M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-32.36M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-66.62M	USD	2 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$15.00K	USD	2 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$416.00K	USD	2 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-169.00K	USD	2 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$36.00K	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-180.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-62.69M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-32.54M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-66.21M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-31.92M	USD	1 Quarter

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-31.95M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-62.53M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-32.36M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-66.62M	USD	2 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.38M	USD	2 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.43M	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-612.00K	USD	2 Qtrs
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.23M	USD	2 Qtrs
Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-74.00K	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$4.81M	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$7.91M	USD	2 Qtrs
Non-Cash Expense	`AmortizationOfDebtDiscountPremium`	$144.00K	USD	2 Qtrs
Non-Cash Expense	`AmortizationOfDebtDiscountPremium`	$1.64M	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$7.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$146.00K	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.12M	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.84M	USD	2 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$98.00K	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-10.21M	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.52M	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-803.00K	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.01M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-57.35M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-68.73M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$86.34M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$149.37M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$164.43M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$120.05M	USD	2 Qtrs
Investment in Other	`PaymentsToAcquireOtherInvestments`	$1.80M	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.11M	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.31M	USD	2 Qtrs
Net Cash Provided by (Used in) Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$26.21M	USD	2 Qtrs
Net Cash Provided by (Used in) Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-81.20M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$2.55M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$188.84M	USD	2 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$3.26M	USD	2 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$349.00K	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$192.10M	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.90M	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$15.00K	USD	2 Qtrs
Net (Decrease) Increase in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-39.63M	USD	2 Qtrs
Net (Decrease) Increase in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$53.56M	USD	2 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$81.58M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$32.48M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$28.02M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$72.11M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$81.58M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$32.48M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$28.02M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$72.11M	USD	Point-in-time
Acquisition of Property and Equipment included in Accounts Payable and Accrued Expenses	`CapitalExpendituresIncurredButNotYetPaid`	$503.00K	USD	2 Qtrs
Acquisition of Property and Equipment included in Accounts Payable and Accrued Expenses	`CapitalExpendituresIncurredButNotYetPaid`	$108.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.